# EDGAR Filing Document

**Accession Number:** 0001749704
**File Stem:** 0001104659-23-002073
**Filing Date:** 2023-1
**Character Count:** 128643
**Document Hash:** b059ea6597e377b39fab88a5d229e194
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-002073.hdr.sgml**: 20230109

**ACCESSION NUMBER**: 0001104659-23-002073

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20230106

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230109

**DATE AS OF CHANGE**: 20230109

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AGILITI, INC. \DE
- **CENTRAL INDEX KEY:** 0001749704
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISCELLANEOUS EQUIPMENT RENTAL & LEASING [7350]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40361
- **FILM NUMBER:** 23516690

**BUSINESS ADDRESS:**
- **STREET 1:** 11095 VIKING DRIVE, SUITE 300
- **CITY:** EDEN PRAIRIE
- **STATE:** MN
- **ZIP:** 55344
- **BUSINESS PHONE:** 952-893-3200

**MAIL ADDRESS:**
- **STREET 1:** 11095 VIKING DRIVE, SUITE 300
- **CITY:** EDEN PRAIRIE
- **STATE:** MN
- **ZIP:** 55344

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): January 6, 2023**

**AGILITI, INC.**

**(Exact name of Registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-40361** | **83-1608463** |
| **(State or other jurisdiction** | **(Commission** | **(I.R.S. Employer** |
| **of incorporation)** | **File Number)** | **Identification No.)** |

---

**11095 Viking Drive, Suite 300**

**Eden Prairie, MN 55344**

**(Address of principal executive offices, including zip code)**

**(952) 893-3200** 

**(Registrant's telephone number, including area code)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

◻ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol | Name of each exchange on which<br> registered |
| Common Stock, par value $0.0001 | AGTI | The New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

*Resignation of Thomas J. Leonard as Chief Executive Officer*

On January 6, 2023, Thomas J. Leonard, Chief Executive Officer and a member of the Board of Directors (the "Board") of Agiliti, Inc. (the "Company"), notified the Chairman of the Board of his decision to retire and resign from his position as Chief Executive Officer of the Company effective as of March 10, 2023 (the "Resignation Date"). Subsequent to the Resignation Date, Mr. Leonard will remain employed by the Company in an advisory role though March 31, 2023 (the "Transition Date"). Mr. Leonard will continue to serve as a member of the Board indefinitely.

On January 6, 2023 (the "Effective Date"), Mr. Leonard and the Company entered into a Transition Agreement (the "Transition Agreement"), pursuant to which, from the Effective Date through the Transition Date, Mr. Leonard will (i) continue to receive his current annualized base salary as provided pursuant to his Employment Agreement, dated March 5, 2019, by and between Mr. Leonard and the Company (the "Employment Agreement"), (ii) be eligible to receive an annual bonus with respect to the 2022 fiscal year in an amount determined based on the criteria set forth in the Company's annual bonus plan and payable in a lump sum at the same time as other executives of the Company (iii) continue to vest in his equity awards that are outstanding as of the Effective Date pursuant to the terms of the applicable award agreements and (iv) subject to his execution of a release of claims, be eligible to receive a pro-rata annual bonus at target performance for the portion of the 2023 fiscal year that has elapsed prior to the Resignation Date, payable in a lump sum on the Transition Date. Additionally, during the portion, if any, of the period between the Transition Date and December 31, 2023 in which Mr. Leonard is eligible to and elects to continue coverage for himself and his eligible dependents, if any, under the Company's group health plans pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, the Company shall, at its option, pay or reimburse Mr. Leonard on a monthly basis or the difference between the amount Mr. Leonard pays to effect and continue such coverage and the employee contribution amount that similarly situated employees of the Company pay for the same or similar coverage under such group health plans.

On the Resignation Date, provided that Mr. Leonard executes the release of claims attached to the Transition Agreement, Mr. Leonard will receive the orderly transition benefits set forth in the Employment Agreement (the "Orderly Transition Benefits"). The Orderly Transition Benefits include (i) the vesting on the Resignation Date of any of his stock options that are scheduled to vest in the 24 months following the Resignation Date and (ii) deemed satisfaction of the time vesting component of all outstanding performance restricted stock units ("PRSUs") held by Mr. Leonard with respect to a pro-rated portion of the PRSUs based on (A) the number of days Mr. Leonard would have provided services during the applicable performance period if he had continued to provide services to the Company through the second anniversary of the Resignation Date in comparison to (B) the total number of days in the applicable performance period. Those PRSU awards will remain subject to achievement of the applicable performance metrics.

In addition, as of the Transition Date, Mr. Leonard will also be entitled to receive the same cash and equity compensation provided to other non-employee directors of the Board for his service as a non-employee director.

The Transition Agreement also provides for customary restrictive covenants with a restricted period of two years, commencing on the date on which Mr. Leonard's service as a non-employee director of the Board terminates, including a non-solicitation of employees, a non-compete and an indefinite non-disclosure provision.

*Appointment of Thomas W. Boehning as Chief Executive Officer*

On January 6, 2023, the Board appointed Thomas W. Boehning, who currently serves as the Company's President, as Chief Executive Officer to succeed Mr. Leonard effective as of the Resignation Date. In addition, the Board approved, that effective as of the Resignation Date, the size of the Board will be increased without any further action and appointed Mr. Boehning as a Class III director effective as of such date.

In connection with his appointment as Chief Executive Officer, Mr. Boehning and the Company entered into an Amended and Restated Employment Agreement, effective as of January 10, 2023, (the "A&R Employment Agreement"), which will replace his current employment agreement with the Company as of such date.

Pursuant to the A&R Employment Agreement, Mr. Boehning is entitled to receive an annualized base salary of $978,500, subject to such increases, if any, as may be determined from time to time in the sole discretion of the Board. Additionally, Mr. Boehning will be eligible to earn an annual bonus of 100% of his base salary, based upon his achievement and the Company's achievement of annual performance targets established by the Board at the beginning of each such calendar year. In addition, Mr. Boehning will be eligible to receive annual awards under the Agiliti, Inc. 2018 Omnibus Incentive Plan, or such other equity incentive plan of the Company as may be in effect from time to time, with such amounts and on such terms and conditions as the Board or a committee thereof shall determine, and subject to the terms and provisions of the incentive plan as in effect and the award agreements evidencing such awards.

In the event Mr. Boehning's employment is terminated by the Company without Cause (as defined in the A&R Employment Agreement) or by Mr. Boehning for Good Reason (as defined in the A&R Employment Agreement) (in each case, other than due to death or disability), then Mr. Boehning will be entitled to: (i) (1) payment of his accrued and unpaid base salary, (2) payment for any accrued but unused vacation days, (3) payment of any earned but unpaid annual bonus with respect to the year prior to the year of termination and (4) reimbursement of out-of-pocket expenses accrued in connection with the performance of Mr. Boehning's duties under his A&R Employment Agreement, in each case of (1) through (4), accrued through the date of termination and (5) all other accrued amounts or accrued benefits due to Mr. Boehning in accordance with the Company's benefit plans, programs or policies (other than severance). (the "Accrued Benefits"); (ii) if the termination occurs prior to a Change in Control or more than two years after a Change in Control, an amount equal to the sum of (A) 12 months of Mr. Boehning's base salary and (B) Mr. Boehning's target bonus opportunity for the year of termination, payable in substantially equal installments over the 12-month period following the date of termination; (iii) if the termination occurs on or within two years after a Change in Control, an amount equal to the sum of (A) 24 months of Mr. Boehning's base salary and (B) two times Mr. Boehning's target bonus opportunity for the year of termination, payable in a lump sum; (iv) a lump-sum payment equal to a pro-rata portion of Mr. Boehning's annual bonus for the year of termination (the "Pro-Rata Bonus"); (v) a lump sum payment equivalent to the amount the COBRA premium would be for his health coverage prior to the termination (for Mr. Boehning and his family to the extent applicable) multiplied by twelve; (vi) immediate vesting as of the date of termination of any options and restricted stock units that would have otherwise vested during the 12 months following such termination of employment or, if Mr. Boehning's termination of employment occurs on or within one year after a Change in Control, immediate vesting as of the date of termination of all such awards and (vii) performance restricted stock units will vest based on actual performance through the date of termination and projected performance from such date of termination through the end of the applicable performance period, with the shares earned pursuant to such performance restricted stock units prorated based on the number of days Mr. Boehning would have been employed during the performance period if Mr. Boehning had remained employed through the first anniversary of the date of termination in comparison to the total number of days in the performance period or, if Mr. Boehning's termination of employment occurs on or within one year after a Change in Control, such awards will vest based on the greater of (A) actual performance as of the Change in Control, as determined by the compensation committee in its sole discretion, and (B) target performance.

In the event Mr. Boehning's employment is terminated by the Company with Cause or by Mr. Boehning without Good Reason (in each case, other than due to death or disability), then Mr. Boehning will be entitled to the Accrued Benefits. In the event Mr. Boehning's employment is terminated by the Company due to Mr. Boehning's death or disability, then Mr. Boehning will be entitled to: (i) an amount equal to the sum of 12 months of his base salary in effect immediately prior to his termination, (ii) the pro-rata bonus, and (iii) the Accrued Benefits.

Payment of the foregoing benefits in each case is conditioned upon Mr. Boehning's compliance with his ongoing obligations to the Company and timely execution of required agreements as specified in the A&R Agreement. The A&R Employment Agreement provides for customary restrictive covenants with a restricted period of two years commencing on the date of Mr. Boehning's termination of employment with the Company, including a non-solicitation of employees, a non-compete and an indefinite non-disclosure and non-disparagement provision.

Mr. Boehning's biography was included in the proxy statement for the Company's 2022 Annual Meeting of Shareholders filed with the SEC on March 25, 2022 and is incorporated herein by reference.

The Company is not aware of any direct or indirect material interest in any transaction between Mr. Boehning and the Company that would require disclosure under Item 404(a) of Regulation S-K and there are no arrangements or understandings between Mr. Boehning and any other person relating to Mr. Boehning's appointment as Chief Executive Officer of the Company. Mr. Boehning does not have any family relationships with any director, executive officer or person nominated or chosen by the Company to become an executive officer of the Company.

The foregoing is not a complete description of the parties' rights and obligations under the Transition Agreement or the A&R Employment Agreement and is qualified in its entirety by reference to the full text and terms of the applicable agreement, which are filed as Exhibits 10.1 and 10.2, respectively, to this Current Report on Form 8-K, and incorporated herein by reference.

**Item 7.01. Regulation FD Disclosure.**

On January 9, 2023, the Company issued a press release announcing the CEO succession described above. A copy of such press release is attached hereto and furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

**Item 9.01. Financial Statements and Exhibits.**

---

| | |
|:---|:---|
| **Exhibit<br> Number** | **Description** |
| [10.1](tm232546d1_ex10-1.htm) | [Transition Agreement, dated as of January 6, 2023, by and between Agiliti, Inc. and Thomas J. Leonard](tm232546d1_ex10-1.htm) |
| [10.2](tm232546d1_ex10-2.htm) | [Amended and Restated Employment Agreement, effective January 10, 2023, by and between Agiliti, Inc. and Thomas W. Boehning](tm232546d1_ex10-2.htm) |
| [99.1](tm232546d1_ex99-1.htm) | [Press Release, dated January 9, 2023](tm232546d1_ex99-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**Signature**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: January 9, 2023

---

| | |
|:---|:---|
| AGILITI, INC. | AGILITI, INC. |
| By: | /s/ James B. Pekarek |
| Name: | James B. Pekarek |
| Title: | Executive Vice President and Chief Financial Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**<u>TRANSITION AGREEMENT</u>**

This Transition Agreement (this "***Agreement***") is entered into by and between Thomas J. Leonard ("***Executive***") and Agiliti, Inc., a Delaware corporation (the "***Company***"). Executive and the Company are each referred to herein as a "***Party***" and together as the "***Parties***."

WHEREAS, Executive is currently employed by the Company as the Company's Chief Executive Officer pursuant to that certain Employment Agreement dated March 5, 2019, by and between Executive and the Company (the "***Employment Agreement***");

WHEREAS, Executive desires to resign from his role as the Company's Chief Executive Officer effective as of March 10, 2023 (the "***Resignation Date***");

WHEREAS, Executive will remain an employee of the Company from the Resignation Date until March 31, 2023 (the "***Transition Date***"), and Executive's employment with the Company and all other Company Parties (as defined below) will automatically terminate on the Transition Date;

WHEREAS, following the Transition Date, Executive will continue to serve on the Company's Board of Directors (the "***Board***") as a non-employee director;

WHEREAS, pursuant to the Section 10(d) of the Employment Agreement, upon the Resignation Date, Executive will receive certain orderly transition benefits, provided that Executive timely executes (and does not revoke) this Agreement and complies with the terms of this Agreement; and

WHEREAS, the Parties wish to resolve any and all claims or causes of action that Executive has or may have against the Company or any of the other Company Parties, including any claims or causes of action that Executive may have arising out of Executive's employment or the end of such employment.

NOW, THEREFORE, in consideration of the promises set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the Parties, the Parties agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.** **<u>Transition of Duties; Termination of Employment</u>**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Between the date Executive signs this Agreement and the Resignation Date, Executive will continue to serve as the Company's Chief Executive Officer and will assist the Company in transitioning the duties of the Chief Executive Officer position to Executive's successor and will provide those services that the Board may reasonably request of Executive from time to time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Between the Resignation Date and the Transition Date, Executive will remain an employee of the Company and will provide those services that the Board may reasonably request of Executive from time to time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Between the date Executive signs this Agreement and the Transition Date (such period, the "***Transition Period***"), Executive's employment shall remain subject to the terms and conditions set forth in the Employment Agreement (except as provided pursuant to Section 1(a) of this Agreement). For the avoidance of doubt, during the Transition Period, Executive will (i) continue to receive his current annualized base salary as provided pursuant to the Employment Agreement, (ii) be eligible to receive an annual bonus with respect to the 2022 fiscal year in an amount determined based on the criteria set forth in the Company's annual bonus plan and payable in a lump sum at the same time as other executives of the Company receive their annual bonuses for the 2022 fiscal year, (iii) continue to vest in Executive's equity awards outstanding as of the date of this Agreement, pursuant to the terms and conditions of the applicable award agreements (the "***Award Agreements***") and (iv) subject to Executive's execution of the Release of claims attached hereto as Exhibit A (the "***Release***") pursuant to the terms and within the applicable time period set forth therein, be eligible to receive a pro-rata annual bonus at target performance for the portion of the 2023 fiscal year that has elapsed prior to the Resignation Date (the "***2023 Pro-Rata Bonus***"), payable in a lump sum on the Transition Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) During the portion, if any, of the period between the Transition Date and December 31, 2023 in which Executive is eligible to and elects to continue coverage for Executive and Executive's spouse and eligible dependents, if any, under the Company's group health plans pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended ("***COBRA***"), the Company shall, at its option, pay or reimburse Executive on a monthly basis for the difference between the amount Executive pays to effect and continue such coverage and the employee contribution amount that similarly situated employees of the Company pay for the same or similar coverage under such group health plans (the "***COBRA Benefit***"). Each payment of the COBRA Benefit shall be paid on or about the Company's first regularly scheduled pay date in each calendar month occurring during such period. Executive shall be eligible to receive such reimbursement payments until the earlier of: (i) December 31, 2023 and (ii) the date Executive is no longer eligible to receive COBRA continuation coverage; *provided, however*, that the election of COBRA continuation coverage and the payment of any premiums due with respect to such COBRA continuation coverage shall remain Executive's sole responsibility, and the Company shall not assume any obligation for payment of any such premiums relating to such COBRA continuation coverage.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) As of the Transition Date, Executive (i) will have no further employment relationship with the Company, its subsidiaries and other affiliates, successors, past and present officers, directors, committees, employees, insurers, agents, attorneys, associates and employee benefit plans (collectively, the "***Company Parties***" or any one, individually, a "***Company Party***"), (ii) will be deemed to have automatically resigned as an officer of the Company and each affiliate of the Company for which Executive served as an officer and (iii) shall continue to serve on the Board as a non-employee director.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) During Executive's tenure as a non-employee director of the Board, Executive will be expected to perform services traditionally associated with a non-employee director of the Board (the "***Services***"). As full payment for Executive's performance of the Services, the Company will pay to Executive the same cash and equity compensation provided to other non-employee directors of the Board during such time as Executive performs the Services. For the avoidance of doubt, for purposes of Section 6.4 of the Agiliti, Inc. 2018 Omnibus Incentive Plan with respect to any of Executive's outstanding stock options, a "Termination" shall not occur until the date on which Executive's service as a non-employee director of the Board terminates (the date of such termination, the "***Separation Date***").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.** **<u>Separation from Service; Deemed Resignations</u>**. Executive's performance of the Services as a non-employee director of the Board shall end upon the Separation Date. Executive acknowledges and agrees that, as of the Separation Date, Executive will be deemed to have automatically resigned as, to the extent applicable, from the board of directors or board of managers (or similar governing body) of: (a) the Company and each affiliate of the Company for which Executive served as a director or manager and (b) any corporation, limited liability entity, unlimited liability entity or other entity in which the Company or any other affiliate of the Company holds an equity interest and with respect to which board of directors or board of managers (or similar governing body) Executive served as the Company's or such other affiliate's member's designee or other representative. Executive agrees to take any further actions that the Company reasonably requests to effectuate or document the foregoing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.** **<u>Orderly Transition Benefits</u>**. Provided that Executive (a) returns an executed copy of the Release to the Company, c/o Lee Neumann, General Counsel, 11095 Viking Drive, Suite 300, Eden Prairie, MN 55344 or via email to Lee.Neumann@AgilitiHealth.com, within the applicable time period set forth therein and (b) abides by the terms hereof (including those terms set forth in <u>Section 5</u>), Executive shall receive the orderly transition benefits set forth in Section 10(d) of the Employment Agreement on the Resignation Date (the "***Orderly Transition Benefits***").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.** **<u>Satisfaction of All Leaves and Payment Amounts; Prior Rights and Obligations</u>**. In entering into this Agreement, Executive expressly acknowledges and agrees that Executive has received all leaves (paid and unpaid) to which Executive has been entitled during Executive's employment with the Company or any other Company Party, and Executive has received all wages, bonuses and other compensation, been provided all benefits and been afforded all rights and been paid all sums that Executive is owed or has been owed by the Company or any other Company Party, including all payments arising out of all incentive plans and any other bonus arrangements. Additionally, Executive will not be entitled to receive any severance benefits pursuant to Section 10(a) of the Employment Agreement. Notwithstanding the foregoing, Executive remains entitled to receive Executive's current annualized base salary and benefits for services performed between the date that Executive signs this Agreement and the Transition Date. For the avoidance of doubt, Executive acknowledges and agrees that Executive had no right to the Orderly Transition Benefits or the 2023 Pro-Rata Bonus (or any portion thereof) but for Executive's execution and re-execution of the Release in accordance with the terms of the Release.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.** **<u>Restrictive Covenants</u>**. Executive hereby affirms that the restrictive covenants and other post-employment obligations contained in the Employment Agreement and any other agreement to which Executive is a party, including, but not limited to, any employment agreement, equity subscription, equity grant agreement or limited liability company agreement with respect to any equity interest in the Company or any of their respective affiliates are and shall remain in effect and enforceable in accordance with their terms and Executive hereby reaffirms the existence and reasonableness of those obligations (including any confidentiality, non-solicitation, non-competition, non-disparagement, intellectual property restrictions or any similar restrictive covenant obligation) (collectively, the "***Restrictive Covenants***"). In entering into this Agreement, Executive acknowledges the continued effectiveness and enforceability of the Restrictive Covenants, and expressly reaffirms Executive's commitment to abide by (and agrees that he will abide by) the terms of the Restrictive Covenants. All of Executive's post-employment obligations under the Restrictive Covenants will begin on the Separation Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.** **<u>Entire Agreement</u>**. This Agreement, the Employment Agreement and the Award Agreements constitute the entire agreement of the Parties with regard to the subject matter hereof and supersede all prior and contemporaneous agreements and understandings, oral or written, between Executive and any Company Party with regard to the subject matter hereof. No modifications or waiver of any provision hereof shall be effective unless in writing and signed by each Party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.** **<u>Governing Law and Jurisdiction</u>**. This Agreement shall be construed according to the laws of the State of Minnesota without regard to its conflict of laws principles that would result in the application of the laws of another jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.** **<u>Arbitration</u>**. Any dispute, controversy, or claim between Executive, on the one hand, and the Company or any other Company Party, on the other hand, arising out of, under, pursuant to, or in any way relating to this Agreement will be subject to the arbitration provision set forth in Section 17(j) of the Employment Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.** **<u>Headings; Interpretation</u>**. Titles and headings to Sections hereof are for the purpose of reference only and shall in no way limit, define or otherwise affect the provisions hereof. Unless the context requires otherwise, all references herein to a law, regulation, agreement, instrument or other document shall be deemed to refer to such law, regulation, agreement, instrument or other document as amended, supplemented, modified and restated from time to time to the extent permitted by the provisions thereof, and references to particular provisions of laws or regulations include a reference to the corresponding provisions of any succeeding law or regulation. The word "or" as used herein is not exclusive and is deemed to have the meaning "and/or." The words "herein," "hereof," "hereunder" and other compounds of the word "here" shall refer to the entire Agreement, and not to any particular provision hereof. The use herein of the word "including" following any general statement, term or matter shall not be construed to limit such statement, term or matter to the specific items or matters set forth immediately following such word or to similar items or matters, whether or not non-limiting language (such as "without limitation," "but not limited to," or words of similar import) is used with reference thereto, but rather shall be deemed to refer to all other items or matters that could reasonably fall within the broadest possible scope of such general statement, term or matter. Neither this Agreement nor any uncertainty or ambiguity herein shall be construed or resolved against any Party, whether under any rule of construction or otherwise. On the contrary, this Agreement has been reviewed by each of the Parties and shall be construed and interpreted as if drafted jointly by the Parties and according to the ordinary meaning of the words used so as to fairly accomplish the purposes and intentions of the Parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.** **<u>Third Party Beneficiaries</u>**. Each Company Party that is not a signatory hereto shall be a third-party beneficiary of Executive's covenants, warranties, representations and release of claims set forth in this Agreement and entitled to enforce such provisions as if it was a party hereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.** **<u>Return of Property</u>**. Executive represents and warrants to the other Parties that Executive has returned, or within five days following the Separation Date, Executive will have returned, to the Company all property belonging to the Company and any other Company Party, including all computer files and other electronically stored information, applicable passwords and other materials provided to Executive by the Company or any other Company Party in the course of Executive's employment, and Executive further represents and warrants to the other Parties that Executive has not maintained or, after the date that is two days following the Separation Date, Executive will not maintain, a copy of any such materials in any form.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12.** **<u>Cooperation</u>**. Following the Transition Date, upon request from the Company or any other Company Party, Executive agrees to cooperate with members of the Company Party as well as their respective counsel, agents or other designees, in order to provide such information and assistance as the Company or such other Company Party may reasonably request with respect to the duties that Executive had performed for any Company Party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**13.** **<u>No Waiver</u>**. No failure by any Party at any time to give notice of any breach by the other Party of, or to require compliance with, any condition or provision of this Agreement shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**14.** **<u>Assignment</u>**. This Agreement is personal to Executive and may not be assigned by Executive. The Company may assign its rights and obligations under this Agreement without Executive's consent, including to any other Company Party and to any successor (whether by merger, purchase or otherwise) to all or substantially all of the equity, assets or businesses of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**15.** **<u>Severability and Modification</u>**. To the extent permitted by applicable law, the Parties agree that any term or provision of this Agreement (or part thereof) that renders such term or provision (or part thereof) or any other term or provision (or part thereof) of this Agreement invalid or unenforceable in any respect shall be severable and shall be modified or severed to the extent necessary to avoid rendering such term or provision (or part thereof) invalid or unenforceable, and such severance or modification shall be accomplished in the manner that most nearly preserves the benefit of the Parties' bargain hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**16.** **<u>Withholding of Taxes and Other Employee Deductions</u>**. The Company may, or may direct any other Company Party to, withhold from any payment made pursuant to this Agreement all federal, state, local, and other taxes as may be required pursuant to any law or governmental regulation or ruling.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**17.** **<u>Representation by Counsel</u>**. Executive acknowledges and agrees that Executive was represented by counsel in connection with the negotiation of this Agreement. Executive acknowledges and agrees that the Company's principal place of business and headquarters are located in Minneapolis, Minnesota, and even though Executive may not be physically located in the State of Minnesota at all times for the performance of all of Executive's duties and responsibilities under this Agreement, Executive will be required to travel routinely to Minnesota on business on behalf of the Company and Executive's employment is effectively providing services to the Company within the State of Minnesota. Executive further acknowledges and agrees that pursuant to Section 925 of the California Labor Code, (i) Executive has waived the application of California law to this Agreement and any proceeding under this Agreement, (ii) Executive has waived any right to have any proceeding under this Agreement adjudicated in California, and (iii) Executive acknowledges and agrees that any proceeding shall not be deemed to be a controversy arising in California. Executive acknowledges that Executive has had sufficient time to and has carefully read and fully understands all the provisions of this Agreement, and is knowingly and voluntarily entering into this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**18.** **<u>Counterparts</u>**. This Agreement may be executed in one or more counterparts (including portable document format (.pdf) and facsimile counterparts), each of which shall be deemed to be an original, but all of which together will constitute one and the same agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**19.** **<u>Section 409A</u>**. This Agreement and the payments provided hereunder are intended be exempt from the requirements of Section 409A of the Internal Revenue Code of 1986, as amended, and the Treasury regulations and interpretive guidance issued thereunder (collectively, "***Section 409A***") and shall be construed and administered in accordance with such intent. Notwithstanding the foregoing, the Company makes no representations that the benefits provided under this Agreement are exempt from the requirements of Section 409A and in no event shall the Company or any other Company Party be liable for all or any portion of any taxes, penalties, interest, or other expenses that may be incurred by Executive on account of non-compliance with Section 409A.

[*Remainder of Page Intentionally Blank;*

*Signature Page Follows.*]

IN WITNESS WHEREOF, Executive and the Company each have caused this Agreement to be executed, as of the dates set forth beneath their names below and effective for all purposes as provided above.

---

| |
|:---|
| **EXECUTIVE** |
| /s/ THOMAS J. LEONARD |
| Thomas J. Leonard |

---

Date: <u>January 6, 2023</u>

---

| | | |
|:---|:---|:---|
| **AGILITI, INC.** | **AGILITI, INC.** | **AGILITI, INC.** |
| By: | /s/ ROBERT L. CREVISTON | /s/ ROBERT L. CREVISTON |
|  | Name: | Robert L. Creviston |
|  | Title: | Chief Human Resources Officer |

---

Date: <u>January 6, 2023</u>

Signature Page to

Transition Agreement

**<u>EXHIBIT A</u>**

**RELEASE OF CLAIMS**

This Release ("***Release***") is entered into by Thomas J. Leonard ("***you***") pursuant to the Transition Agreement to which this Release is attached.

**<u>Release of Claims</u>**

In consideration of the benefits provided under the Transition Agreement to which this Release is attached, you agree on your own behalf and on behalf of anyone claiming rights through you, to fully and finally release, waive and forever discharge Agiliti, Inc. (the "***Company***"), its subsidiaries and other affiliates, successors, past and present officers, directors, committees, employees, insurers, agents, attorneys, associates and employee benefit plans (collectively "***Released Parties***") from all claims, demands or causes of action arising out of facts or occurrences before and as of the date of this Release, whether known or unknown to you; however, you are not prohibited from pursuing claims for any employee benefit vested and accrued in your favor as of your Resignation Date, with respect to the initial execution of this Release, or the Transition Date, with respect to the re-execution of this Release.

You agree that this Release is intended to be broadly construed so as to resolve any pending and potential disputes between you and the Released Parties that you have up to the date of your acceptance of this Release, whether such disputes are known or unknown to you, including, but not limited to, claims based on express or implied contract; any administrative agency action or proceeding to the extent allowed by law; any action arising in tort, including, but not limited to interference with contractual or business relationships, breach of fiduciary duty, promissory or equitable estoppel, invasion of privacy, libel, slander, defamation, intentional infliction of emotional distress, or negligence; any or all claims for wrongful discharge, breach of a covenant of good faith and fair dealing; and any and all claims including but not limited to those based on the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act, Title VII of the Civil Rights Act, the Civil Rights Act of 1991, the Employment Retirement Income Security Act, the Family and Medical Leave Act, the Americans With Disabilities Act, the State of Minnesota Human Rights Act, other applicable state human rights laws and any other applicable federal, state, local or foreign law, regulation, ordinance or order. The above release of claims does not include any claims that the law does not allow to be waived or any claims that may arise after the date you sign this Release, nor does it prohibit you from filing any charge or complaint with, or participating in any investigation or proceeding conducted by, the Equal Employment Opportunity Commission ("***EEOC***"). Notwithstanding the foregoing, you release and waive any right you may have to obtain monetary relief or compensation awarded by the EEOC. You further agree to not voluntarily assist or participate in any lawsuits brought by other individuals against the Released Party, unless such assistance is requested by the Company or the Released Party.

**<u>Acceptance of this Release</u>**

You acknowledge that, before signing this Release, you were given a period of at least 21 days from the date of receipt of this Release to consider it. To accept the terms of this Release, you must sign and date it within the 21-day consideration period or by the end of the workday on your Resignation Date, whichever is later. **You may not sign this Release before your Resignation Date.** After you have signed and dated this Release, you must send or return it to the Company by hand or by mail within the 21-day period that you have to consider it. Any changes to this Release whether material or not will not restart the running of the 21-day period.

To accept this Release, sign and return it to the Company, c/o Lee Neumann, General Counsel, 11095 Viking Drive, Suite 300, Eden Prairie, MN 55344 or via email to Lee.Neumann@AgilitiHealth.com.

If you choose to return this Release by mail, it must be properly addressed and postmarked within the 21-day consideration period and sent by certified mail, return receipt requested, first-class postage prepaid.

If you sign this Release before the end of the 21-day consideration period, it will be your voluntary decision to do so because you have decided that you do not need any additional time to decide whether to sign it. You waive any right you might have to additional time beyond the 21-day consideration period within which to consider this Release.

You have been advised by the Company to consult with an attorney before signing this Release and this sentence constitutes such advice in writing.

**<u>Rescission of this Release</u>**

At any time for a period of 15 days after you have signed this Release (not counting the day you signed it), you may rescind it. This Release will not become effective or enforceable until the 15-day rescission period has expired without you rescinding it. To rescind your acceptance, you must send by mail or hand-deliver a written, signed statement of rescission of your acceptance to the Company within the 15-day rescission period. Any statement of recession of acceptance must be directed to the Company, c/o Lee Neumann, General Counsel, 11095 Viking Drive, Suite 300, Eden Prairie, MN 55344 or via email to Lee.Neumann@AgilitiHealth.com. If you choose to return it by mail, it must be properly addressed and postmarked within 15 days after you signed the Release and sent by certified mail, return receipt requested, first-class postage prepaid.

**<u>Governing Law and Construction</u>**

This Release may not be changed, except in a writing that details the change and is signed by both you and the Company.

This Release will be governed and enforced solely under the laws of the State of Minnesota, without giving effect to the conflicts of law principles thereof. If any portion of this Release is deemed to be invalid or unenforceable, that portion will be deemed omitted and the remainder of this Release will remaining effect.

**<u>Remedies for Breach</u>**

If you breach or challenge the enforceability of this Release and do not prevail, you agree to reimburse the Company for any monetary consideration received by you pursuant to this Release and you agree to pay the reasonable attorneys' fees and costs that the Company incurs in enforcing this Release; provided, however, that this provision has no applicability to claims that cannot be waived under the Age Discrimination in Employment Act, including the right to challenge whether this Release constitutes a knowing and voluntary waiver of claims within the meaning of the Act.

**<u>Re-Execution of Release</u>**

The Company's obligations with respect to the 2023 Pro-Rata Bonus under the Transition Agreement to which this Release is attached are strictly contingent upon Executive's re-execution and non-revocation of the Release on the Separation Date or within 21 days thereafter. The date of Executive's re-execution of the Release is referred to herein as the "***Re-Execution Date***". By re-executing the Release, Executive advances to the Re-Execution Date Executive's release of all claims against the Released Parties. Executive has 15 calendar days from the Re-Execution Date to revoke Executive's re-execution of this Release. In the event of such revocation by Executive, the date of the releases shall not be advanced, but shall remain effective up to and including the date upon which Executive originally signs this Release.

**<u>Acknowledgement</u>**

**By my signature below, I acknowledge and certify that:**

a. I have read and understand all of the terms
 of this Release and do not rely on any representation or statement, written or oral, not
 set forth in this Release; specifically, I understand that this Release includes a waiver
 and release of legal rights I may have;

b. I have had a reasonable period of time to
 consider this Release;

c. I am signing this Release knowingly and voluntarily
 and without pressure, and after having given the matter full and careful consideration;

d. I have been advised to consult with an attorney
 of my choosing before signing this Release and I have had the opportunity to do so;

e. I have the right to consider the terms of
 this Release for at least 21 days and if I take fewer than 21 days to review this Release, I
 hereby waive any and all rights to the balance of the 21-day review period;

f. I
 have the right to revoke this Release within 15 days after signing it, by providing written
 notice of revocation directed to the Company, c/o Lee Neumann, General Counsel, 11095
 Viking Drive, Suite 300, Eden Prairie, MN 55344 or via email to Lee.Neumann@AgilitiHealth.com.
 If I revoke this Release during this 15-day period, it becomes null and void in its entirety;
 and

g. This Release is not effective if it is signed
 before my Resignation Date.

If you accept this Release, please sign both copies, and then return both signed original copies to the Company, c/o Lee Neumann, General Counsel, 11095 Viking Drive, Suite 300, Eden Prairie, MN 55344 or via email to Lee.Neumann@AgilitiHealth.com.

---

| |
|:---|
| **<u>EXECUTED</u>** |
| **NOT TO BE SIGNED PRIOR TO THE RESIGNATION DATE** |
| Thomas J. Leonard |
| Date: |
| **<u>RE-EXECUTED</u>** |
| **NOT TO BE SIGNED PRIOR TO THE TRANSITION DATE** |
| Thomas J. Leonard |
| Date: |

---

Signature Page to

Release of Claims

## Exhibit 10.2

**Exhibit 10.2**

**<u>AMENDED & RESTATED EMPLOYMENT AGREEMENT</u>**

THIS AMENDED & RESTATED EMPLOYMENT AGREEMENT (this "<u>Agreement</u>") is entered into and effective as of January 10, 2023 (the "<u>Agreement Effective Date</u>"), by and between Thomas W. Boehning ("<u>Executive</u>") and Agiliti, Inc., a Delaware corporation (the "<u>Company</u>").

**WHEREAS**, the Company and Executive previously entered into that certain employment agreement, dated as of January 20, 2020 (the "<u>Prior Agreement</u>"), providing for Executive's employment with the Company and setting forth the terms and conditions of such employment;

**WHEREAS**, the Company and Executive now wish to amend and restate the Prior Agreement to, among other things, change Executive's title and certain economic terms; and

**WHEREAS**, the Company and Executive are willing to continue Executive's employment with the Company on the terms and conditions set forth in this Agreement.

**NOW**, **THEREFORE**, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. <u>Employment Term</u>. As of the Agreement Effective Date, the Company hereby agrees to continue to employ Executive, and Executive hereby agrees to accept the terms and conditions of employment with the Company contained in this Agreement. Executive's employment pursuant to this Agreement will commence on the Agreement Effective Date and shall continue until terminated pursuant to Section 9, such period hereinafter referred to as the "Term."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. <u>Duties and Location</u>. Beginning on March 10, 2023 (the "<u>CEO Effective Date</u>"), Executive shall have the title of Chief Executive Officer of the Company and shall have such duties, authorities and responsibilities as are consistent with such position and as the Board of Directors of the Company (the "<u>Board</u>") may designate from time to time. Executive shall report directly to the Board. As of the CEO Effective Date, the Company shall appoint Executive as a member of the Board. In connection with any election of directors to the Board during the Term upon the expiration of Executive's then-current term on the Board, the Company shall nominate Executive for re-election to the Board. For the avoidance of doubt, from the Agreement Effective Date through the CEO Effective Date, Executive shall continue to hold the title of President of the Company and shall have such duties, authorities and responsibilities as are consistent with such position and as the Board may designate from time to time.

Executive shall devote his full working time and attention and Executive's best efforts to Executive's employment and service with the Company and shall perform Executive's services in a capacity and in a manner consistent with Executive's position for the Company; <u>provided</u>, that this <u>Section 2</u> shall not be interpreted as prohibiting Executive from (i) managing Executive's personal investments (so long as such investment activities are of a passive nature), (ii) engaging in charitable or civic activities, (iii) participating on boards of directors or similar bodies of non-profit organizations, or (iv) subject to approval by the Board in its sole discretion, participating on boards of directors or similar bodies of for-profit organizations, in each case of (i) – (iv), so long as such activities do not, individually or in the aggregate, (a) materially interfere with the performance of Executive's duties and responsibilities hereunder, (b) create a fiduciary conflict, or (c) result in a violation of <u>Section 14</u> of this Agreement. If requested, Executive shall also serve as an executive officer and/or board member of the board of directors (or similar governing body) of any entity that is a subsidiary of the Company, without any additional compensation. Executive's principal place of employment shall be in the State of Florida but Executive shall be required to travel to and render services at other Company locations, as may reasonably be required by his duties hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. <u>Base Salary</u>. Beginning on the Agreement Effective Date and continuing for the remainder of the Term, the Company shall pay Executive a base salary at an annual rate of $978,500, payable in accordance with the Company's normal payroll practices for employees as in effect from time to time. Executive shall be entitled to such increases (but not decreases) in base salary, if any, as may be determined from time to time in the sole discretion of the Board. Executive's annual base salary, as in effect from time to time, is hereinafter referred to as the "<u>Base Salary</u>."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. <u>Annual Bonus</u>. With respect to each calendar year during the Term, Executive shall be eligible to earn an annual cash bonus award (the "<u>Annual Bonus</u>") of one hundred percent (100%) of Base Salary ("<u>Target Bonus Opportunity</u>"), based upon Executive's achievement and the Company's achievement of annual performance targets established by the Board in its sole discretion after consultation with Executive at the beginning of each such calendar year. The Annual Bonus, if any, for each calendar year during the Term shall be paid to Executive at the same time that other senior executives of the Company receive annual bonus payments, but in no event earlier than January 1st and in no event later than April 15th of the year following the calendar year to which such Annual Bonus relates. Executive shall not be paid any Annual Bonus with respect to a calendar year unless Executive is employed with the Company through the end of the calendar year to which such Annual Bonus relates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. <u>Equity Eligibility</u>. During the Term, Executive shall be eligible to receive annual awards under the Company's 2018 Omnibus Incentive Plan or such other equity incentive plan of the Company as may be in effect from time to time (the "<u>Incentive Plan</u>"). All awards granted to Executive under the Incentive Plan, if any, shall be in such amounts and on such terms and conditions as the Board or a committee thereof shall determine from time to time, and shall be subject to and governed by the terms and provisions of the Incentive Plan as in effect from time to time and the award agreements evidencing such awards. Nothing herein shall be construed to give Executive any rights to any amount or type of grant or award except as provided in an award agreement and authorized by the Board or a committee thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. <u>Benefits</u>. During the Term, Executive shall be entitled to participate in any benefit plans, including medical, disability and life insurance (but excluding any severance or bonus plans unless specifically referenced in this Agreement) offered by the Company as in effect from time to time (each, a "<u>Benefit Plan</u>"), on the same basis as those generally made available to other senior executives of the Company, to the extent consistent with applicable law and the terms of the applicable Benefit Plan. The Company does not promise the adoption or continuance of any particular Benefit Plan and reserves the right to amend or cancel any Benefit Plan at any time in its sole discretion (subject to the terms of such Benefit Plan and applicable law).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. <u>Vacation</u>. Executive will be entitled to vacation and sick time consistent with the Company's executive paid time off policy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. <u>Expense Reimbursement.</u> Executive shall be entitled to reimbursement for all reasonable and necessary out-of-pocket business, entertainment and travel expenses incurred by Executive in connection with the performance of Executive's duties hereunder in accordance with the Company's expense reimbursement policies and procedures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. <u>Termination of Employment</u>. The Term and Executive's employment hereunder may be terminated as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Automatically in the event of the death of Executive;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) At the option of the Company, by written notice to Executive or Executive's personal representative in the event of the Disability of Executive. As used herein, the term "<u>Disability</u>" shall mean Executive is disabled within the meaning of the Company's long-term disability policy then in effect;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) At the option of the Company for Cause, on prior written notice to Executive;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) At the option of the Company at any time without Cause (provided that the assignment of this Agreement to, and assumption of this Agreement by, the purchaser of all or substantially all of the assets of the Company shall not be treated as a termination without Cause under this <u>Section 9(d)</u>), by delivering written notice of its determination to terminate to Executive;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) At the option of Executive for Good Reason;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) At the option of Executive without Good Reason, upon ninety (90) days prior written notice to the Company (which the Company may, in its sole discretion, make effective as a resignation earlier than the termination date provided in such notice; provided that the Company shall continue to pay Executive his Base Salary for such ninety (90) day period).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. <u>Payments by Virtue of Termination of Employment</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Termination by the Company Without Cause or by Executive For Good Reason</u>. If Executive's employment is terminated at any time during the Term by the Company without Cause or by Executive for Good Reason, subject to <u>Section 10(d)</u> of this Agreement, Executive shall be entitled to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) (A) within ten (10) days following such termination, (i) payment of Executive's accrued and unpaid Base Salary, (ii) payment for any accrued but unused vacation days, (iii) payment of any earned but unpaid Annual Bonus with respect to the year prior to the year of termination and (iv) reimbursement of expenses under <u>Section 8</u> of this Agreement, in each case of (i) through (iv), accrued through the date of termination and (B) all other accrued amounts or accrued benefits due to Executive in accordance with the Company's benefit plans, programs or policies (other than severance);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) if the termination occurs prior to a Change in Control or more than two (2) years after a Change in Control, an amount equal to the sum of (A) twelve (12) months of Executive's Base Salary as in effect immediately prior to Executive's date of termination and (B) Executive's Target Bonus Opportunity for the year of termination, which sum shall be payable during the twelve (12) month period commencing on the date of termination in substantially equal installments in accordance with the Company's regular payroll practices as in effect from time to time, <u>provided</u>, that the first payment pursuant to this <u>Section 10(a)(ii)</u> shall be made on the payment date ("<u>Payment Date</u>") determined as (A) the next regularly scheduled payroll date following the second business day after the Release as set forth in <u>Section 10(d)</u> becomes effective and irrevocable (B) unless the sixty (60) day period following Executive's termination spans two calendar years in which event on the next regularly scheduled payroll date following the later of (i) the second business day after the Release becomes effective and irrevocable and (ii) the second business day of the second calendar year in such sixty (60) day period, and in all events payments shall include payment of any amounts that would otherwise be due prior to the Payment Date; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) if the termination occurs on or within two years after a Change in Control, an amount equal to the sum of (A) twenty-four (24) months of Executive's Base Salary as in effect immediately prior to Executive's date of termination and (B) two times Executive's Target Bonus Opportunity for the year of termination, which sum shall be payable in a lump sum on the Payment Date; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) an amount equal to the pro-rata portion of Executive's Annual Bonus for the year of termination, based on the number of days Executive is employed during such year and based on objective actual performance through the date of termination (or the end of the month preceding such termination if such performance is generally determined as of the end of the month), payable in a lump-sum on the Payment Date ("<u>Pro-rata Bonus</u>"); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) a lump sum payment on the Payment Date equivalent to the amount the COBRA premium would be for Executive for the health coverage Executive had prior to the termination (for Executive and his family to the extent applicable) multiplied by (A) twelve (12) if the termination of employment occurs prior to a Change in Control or more than two (2) years after a Change in Control or (B) twenty four (24) if the termination of employment occurs on or within two (2) years following a Change in Control. Executive may but is not required to elect continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended ("<u>COBRA</u>") to receive the payment in this <u>Section 10(a)(v)</u>; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) options and restricted stock units that are subject solely to time-based vesting conditions granted under the Incentive Plan or any other equity plan or program that would otherwise vest during the twelve (12) months following such termination of employment will vest in full immediately upon such termination of employment or, if Executive's termination of employment occurs on or within one (1) year after a Change in Control, such awards will vest in full immediately upon such termination of employment; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) performance restricted stock units granted under the Incentive Plan or any other equity plan or program will vest based on actual performance through the date of Executive's termination of employment and projected performance from the date immediately after Executive's termination of employment through the end of the applicable performance period based on the then current operating budget of the Company (last previously approved by the Board prior to Executive's termination of employment and after consultation with the then current Chief Executive Officer of the Company), with the Shares earned pursuant to such performance restricted stock units prorated based on the number of days Executive would have been employed during the performance period if Executive had remained employed through the first anniversary of the termination of his employment in comparison to the total number of days in the performance period or, if Executive's termination of employment occurs on or within one (1) year after a Change in Control, such awards will vest based on the greater of (A) actual performance as of the Change in Control, as determined by the Committee (as defined in the Incentive Plan) in its sole discretion, and (B) target performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Termination by the Company With Cause or by Executive Without Good Reason</u>. If the Company terminates Executive's employment for Cause during the Term or Executive terminates his employment without Good Reason during the Term, Executive shall be entitled to receive the payments and benefits described under <u>Section 10(a)(i)</u> of this Agreement. In addition, if Executive terminates his employment without Good Reason during the Term, Executive shall be entitled to receive a Pro-rata Bonus.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Termination due to Executive's Death or Disability</u>. If Executive's employment terminates during the Term due to death or Disability, Executive or Executive's legal representatives, as applicable, shall be entitled to (i) an amount equal to the sum of twelve (12) months of Executive's Base Salary as in effect immediately prior to Executive's date of termination, (ii) the Pro-rata Bonus, and (iii) the payments and benefits described under <u>Section 10(a)(i)</u> of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Conditions to Payment</u>. All payments and benefits due to Executive under this <u>Section 10</u> which are not otherwise required by applicable law shall be payable only if Executive executes and delivers to the Company a general release of claims in a form substantially as set forth on Attachment A ("<u>Release</u>") and such Release is no longer subject to revocation (to the extent applicable), in each case, within sixty (60) days following termination of employment. Failure to timely execute and return such Release or revocation thereof shall be a waiver by Executive of Executive's right to severance (which, for the avoidance of doubt, shall not include any amounts described in <u>Section 10(a)(i)</u> of this Agreement). In addition, severance shall be conditioned on Executive's continued compliance with <u>Section 14</u> of this Agreement as provided in <u>Section 16</u> below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>No Other Severance</u>. Executive hereby acknowledges and agrees that, other than the severance payments described in this <u>Section 10</u> upon the effective date of the termination of Executive's employment, Executive shall not be entitled to any other severance payments or benefits of any kind under any Company benefit plan, severance policy generally available to the Company's employees or otherwise and all other rights of Executive to compensation under this Agreement shall end as of such date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. <u>Definitions</u>. For purposes of this Agreement,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) "<u>Affiliate</u>" shall mean any entity that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) "<u>Cause</u>" shall mean, (i) the commission by Executive of, or the indictment of Executive for (or pleading guilty or *nolo contendere* to), a felony or a crime involving moral turpitude, (ii) Executive's repeated failure or refusal to faithfully and diligently perform the usual and customary duties of his employment or to act in accordance with any lawful direction or order of the Board, which failure or refusal is not cured within thirty (30) days after written notice thereof is given to Executive, (iii) Executive's material breach of fiduciary duty, (iv) Executive's theft, fraud, or dishonesty with regard to the Company or any of its Affiliates or in connection with Executive's duties, (v) Executive's material violation of the Company's code of conduct or similar written policies, (vi) Executive's willful misconduct unrelated to the Company or any of its Affiliates having, or likely to have, a material negative impact on the Company or any of its Affiliates (economically or its reputation), (vii) an act of gross negligence or willful misconduct by Executive that relates to the affairs of the Company or any of its Affiliates, or (viii) material breach by Executive of any provisions of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) "<u>Change in Control</u>" shall mean the occurrence, in a single transaction or in a series of related transactions, of any of the following events:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any individual, entity or group (within the meaning of Sections 13(d)(3) of the Securities Exchange Act of 1934, as amended) ("<u>Person</u>") has "beneficial ownership" (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of more than 50% of either (A) the then-outstanding Shares ("<u>Outstanding Company Common Stock</u>") or (B) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors ("<u>Outstanding Company Voting Securities</u>"); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) individuals who, as of the Agreement Effective Date, constitute the Board (the "<u>Incumbent Board</u>") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the date hereof whose election, or nomination for election by the Company's shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) consummation of a reorganization, merger, statutory share exchange or consolidation or similar corporate transaction involving the Company or any entity controlled by the Company, or a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or stock of another entity by the Company or any entity controlled by the Company (each, a "<u>Business Combination</u>"), in each case, unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation or entity resulting from such Business Combination (including, without limitation, a corporation or entity that, as a result of such transaction, owns the Company or all or substantially all of the Company's assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Business Combination of the Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case may be, (B) no Person beneficially owns, directly or indirectly, more than 50% of, respectively, the then-outstanding shares of common stock of the corporation or equity of the entity resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such corporation or entity, and (C) at least a majority of the members of the board of directors or comparable governing body of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board, providing for such Business Combination; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) immediately prior to the complete liquidation or dissolution of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) "<u>Good Reason</u>" shall mean, without Executive's consent, (i) any material diminution in Executive's responsibilities, authorities or duties; provided that in the event of Executive's Disability, the Company's appointment of an interim Chief Executive Officer shall not constitute a diminution of Executive's responsibilities, authorities or duties, (ii) any reduction in Executive's (x) Base Salary or (y) Target Bonus Opportunity (except in the event of an across the board reduction in Base Salary or Target Bonus Opportunity applicable to substantially all senior executives of the Company), (iii) a relocation of Executive's place of employment (as provided in Section 2) by more than fifty (50) miles, (iv) as of the CEO Effective Date, the Company's failure to appoint Executive as CEO and as a member of the Board as required by the terms herein, or (v) in connection with any election of directors to the Board during the Term upon the expiration of Executive's then-current term on the Board, the Company's failure to nominate Executive for re-election to the Board; <u>provided</u>, that no event described in clause (i), (ii) ,(iii), (iv) or (v) shall constitute Good Reason unless (A) Executive has given the Company written notice of the termination, setting forth the conduct of the Company that is alleged to constitute Good Reason, within thirty (30) days following the occurrence of such event, and (B) Executive has provided the Company at least sixty (60) days following the date on which such notice is provided to cure such conduct and the Company has failed to do so. Failing such cure, a termination of employment by Executive for Good Reason shall be effective on the day following the expiration of such cure period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. <u>Return of Company Property</u>. Within ten (10) days following the effective date of Executive's termination for any reason, Executive or Executive's personal representative shall, return all property of the Company or any of its Affiliates in Executive's possession, including, but not limited to, all Company-owned computer equipment (hardware and software), telephones, facsimile machines, tablet computers and other communication devices, credit cards, office keys, security access cards, badges, identification cards and all copies (including drafts) of any documentation or information (however stored) relating to the business of the Company or any of its Affiliates, the Company's or any of its Affiliates' customers and clients or their respective prospective customers or clients. Anything to the contrary notwithstanding, Executive shall be entitled to retain (i) personal papers and other materials of a personal nature; (ii) information showing Executive's compensation or relating to reimbursement of expenses, and (iii) copies of plans, programs and agreements relating to Executive's employment, or termination thereof, with the Company which he received in Executive's capacity as a participant; <u>provided</u>, that, in each case of (i) – (iii), such papers or materials do not include Confidential and Proprietary Information (as defined in <u>Section 14(a)</u>).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. <u>Resignation as Officer or Director</u>. Upon the effective date of any Executive's termination, Executive shall be deemed to have resigned, to the extent applicable, as an officer of the Company, as a member of the board of directors or similar governing body of the Company or any of its Affiliates, and as a fiduciary of any Company benefit plan. On or immediately following the effective date of any such termination of Executive's employment, Executive shall confirm the foregoing by submitting to the Company in writing a confirmation of Executive's resignation(s).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. <u>Confidentiality; Non-Solicitation; Non-Competition; Non-Disparagement</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Confidential and Proprietary Information</u>. Executive agrees that during and at all times after the Term, Executive will keep secret all confidential matters and materials of the Company (including its subsidiaries and affiliates), including, without limitation, know-how, trade secrets, real estate plans and practices, individual office results, customer lists, pricing policies, operational methods, any information relating to the Company (including any of its subsidiaries and affiliates) products, processes, customers and services and other business and financial affairs of the Company (collectively, the "Confidential Information"), to which Executive had or may have access and will not disclose such Confidential Information to any person, other than (i) the Company, its respective authorized employees and such other persons to whom Executive has been instructed to make disclosure by the Board, (ii) as appropriate (as determined by Executive in good faith) to perform his duties hereunder, or (iii) in compliance with legal process or regulatory requirements. "Confidential Information" will not include any information which is in the public domain during or after the Term, provided such information is not in the public domain as a consequence of disclosure by Executive in violation of this Agreement. Executive acknowledges that all discoveries, concepts, ideas, inventions, innovations, improvements, developments, methods, designs, analyses, drawings, reports, patent applications, copyrightable work and mask work (whether or not including any confidential information) and all registrations or applications related thereto, all other proprietary information and all similar or related information (whether or not patentable) which relate to the Company's or any of its subsidiaries' actual or anticipated business, research and development or existing or future products or services and which are conceived, developed or made by Executive (whether above or jointly with others) while employed by the Company or its predecessors and its subsidiaries ("<u>Work Product</u>"), belong to the Company or such subsidiary. Executive shall promptly disclose such Work Product to the Board and, at the Company's expense, perform all actions reasonably requested by the Board (whether during or after the Term) to establish and confirm such ownership (including, without limitation, assignments, consents, powers of attorney and other instruments). Nothing in this Agreement is intended to or will be used in any way to limit Executive's rights to communicate with a government agency or seek and obtain a whistleblower award from a government agency, as provided for, protected under or warranted by applicable law, including Section 21F of the Securities Exchange Act of 1934, as amended. Further, 18 U.S.C. § 1833(b) provides: "An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that—(A) is made—(i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal." Nothing in this Agreement is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by 18 U.S.C. § 1833(b). Accordingly, the parties to this Agreement have the right to disclose in confidence trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law. The parties also have the right to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Non-Solicitation</u>. Executive hereby acknowledges and agrees that during Executive's employment with the Company and for a period of two (2) years commencing with the date of Executive's termination of employment with the Company (the "<u>Restricted Period</u>"), Executive shall not, without the written consent of the Board, directly or indirectly, on Executive's behalf or the behalf of a third party, hire, solicit, persuade or induce to leave, or attempt to do any of the foregoing, any person who is employed by, or performing services as an independent contractor for, the Company or any of its Affiliates as of the date of Executive's termination (or who was an employee or independent contractor of the Company or any of its Affiliates at any time during the twelve (12) months preceding Executive's date of termination).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Non-Competition</u>. Executive hereby acknowledges and agrees that during the Restricted Period, Executive shall not, directly or indirectly, be employed by or otherwise provide services for, including, but not limited to, as a consultant, independent contractor or in any other capacity, or own or invest in (other than ownership for investment purposes of less than two percent (2%) of a publicly traded company) any company or other entity or organization engaged in the business of renting medical equipment products and providing various services related to medical and veterinary equipment including, without limitation, asset recovery and equipment brokerage, biomedical services, asset management, equipment outsourcing and maintenance and repair of medical equipment in the United States of America.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Non-Disparagement</u>. Subject to <u>Section 14(a)</u>, Executive agrees that during the period from and after the Agreement Effective Date, Executive will not (and will not cause or direct any person or entity to), directly or indirectly, at any time, make, publish or communicate to any person, entity or organization any disparaging, negative or defamatory remarks, comments or statements regarding the Company or any of its Affiliates or any of their businesses, products or services or any of its or their current or former employees, investors, members, officers, attorneys, directors, owners, agents, customers, suppliers, investors and other business relations. The Company agrees that it will not issue any press release or other authorized public statement that disparages Executive or otherwise harms the Executive's business interests or reputation and will instruct its Board members and senior executives not to make any such statements to third parties outside of the Company. The provisions of this Section 14(d) shall not apply to (i) statements made in connection with any litigation between the parties hereto, (ii) statements made to any federal, state, or local government or any department, agency, or other subdivision thereof, or (iii) statements that are required by law or legal process.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Tolling</u>. In the event of any violation of the provisions of this <u>Section 14</u>, Executive acknowledges and agrees that the post-termination restrictions contained in this <u>Section 14</u> shall be extended by a period of time equal to the period of such violation, it being the intention of the parties hereto that the running of the applicable post-termination restriction period shall be tolled during any period of such violation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. <u>Cooperation</u>. From and after Executive's termination of employment, Executive shall provide Executive's reasonable cooperation in connection with any action or proceeding (or any appeal from any action or proceeding) which relates to events occurring during Executive's employment hereunder, <u>provided</u>, that the Company shall reimburse Executive for Executive's reasonable costs and expenses (including legal counsel selected by Executive and reasonably acceptable to the Company) and such cooperation shall not unreasonably burden Executive or unreasonably interfere with any subsequent employment that Executive may undertake.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. <u>Injunctive Relief and Specific Performance</u>. Executive understands and agrees that Executive's covenants under <u>Sections 12, 14 and 15</u> are special and unique and that the Company and its Affiliates may suffer irreparable harm if Executive breaches any of <u>Sections 12, 14, or 15</u> because monetary damages would be inadequate to compensate the Company and its Affiliates for the breach of any of these sections. Accordingly, Executive acknowledges and agrees that the Company shall, in addition to any other remedies available to the Company at law or in equity, be entitled to obtain specific performance and injunctive or other equitable relief by a federal or state court in Minnesota to enforce the provisions of <u>Sections 12, 14 and/or 15</u> without the necessity of posting a bond or proving actual damages, without liability should such relief be denied, modified or vacated. Each party shall be responsible for his or its own attorney's fees in respect of any such action or proceeding. Additionally, in the event of a breach or threatened breach by Executive of <u>Section 14</u>, in addition to all other available legal and equitable rights and remedies, the Company shall have the right to cease making payments, if any, being made pursuant to <u>Section 10(a)(ii)</u> hereunder. Executive also recognizes that the territorial, time and scope limitations set forth in <u>Section 14</u> are reasonable and are properly required for the protection of the Company and its Affiliates and in the event that any such territorial, time or scope limitation is deemed to be unreasonable by a court of competent jurisdiction, the Company and Executive agree, and Executive submits, to the reduction of any or all of said territorial, time or scope limitations to such an area, period or scope as said court shall deem reasonable under the circumstances.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. <u>Certain Excise Taxes</u>. Notwithstanding anything to the contrary in this Agreement, if Executive is a "disqualified individual" (as defined in Section 280G(c) of the Internal Revenue Code (the "<u>Code</u>")), and the payments and benefits provided for in this Agreement, together with any other payments and benefits which Executive has the right to receive from the Company or any of its affiliates, would constitute a "parachute payment" (as defined in Section 280G(b)(2) of the Code), then the payments and benefits provided for in this Agreement shall be either (a) reduced (but not below zero) so that the present value of such total amounts and benefits received by Executive from the Company or any of its affiliates shall be one dollar ($1.00) less than three times Executive "base amount" (as defined in Section 280G(b)(3) of the Code) and so that no portion of such amounts and benefits received by Executive shall be subject to the excise tax imposed by Section 4999 of the Code or (b) paid in full, whichever produces the better net after-tax position to Executive (taking into account any applicable excise tax under Section 4999 of the Code and any other applicable taxes). The reduction of payments and benefits hereunder, if applicable, shall be made by reducing, first, payments or benefits to be paid in cash hereunder in the order in which such payment or benefit would be paid or provided (beginning with such payment or benefit that would be made last in time and continuing, to the extent necessary, through to such payment or benefit that would be made first in time) and, then, reducing any benefit to be provided in-kind hereunder in a similar order. The determination as to whether any such reduction in the amount of the payments and benefits provided hereunder is necessary shall be made by the Company in good faith. If a reduced payment or benefit is made or provided and through error or otherwise that payment or benefit, when aggregated with other payments and benefits from the Company or any of its affiliates used in determining if a "parachute payment" exists, exceeds one dollar ($1.00) less than three times Executive's base amount, then Executive shall immediately repay such excess to the Company upon notification that an overpayment has been made. Nothing in this <u>Section 17</u> shall require the Company to be responsible for, or have any liability or obligation with respect to, Executive's excise tax liabilities under Section 4999 of the Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18. <u>Clawback</u>. To the extent required by applicable law or any applicable securities exchange listing standards, or as otherwise determined by the Board (or a committee thereof), amounts paid or payable under this Agreement shall be subject to the provisions of any applicable clawback policies or procedures adopted by the Company, which clawback policies or procedures may provide for forfeiture and/or recoupment of amounts paid or payable under this Agreement. Notwithstanding any provision of this Agreement to the contrary, the Company reserves the right, without the consent of Executive, to adopt any such clawback policies and procedures, including such policies and procedures applicable to this Agreement with retroactive effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19. <u>Miscellaneous</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All notices hereunder, to be effective, shall be in writing and shall be deemed effective when delivered by hand or mailed by (i) certified mail, postage and fees prepaid, or (ii) nationally recognized overnight express mail service, as follows:

---

| |
|:---|
| If to the Company: |
| Agiliti, Inc. |
| 11095 Viking Drive, Suite 300 |
| Eden Prairie, MN 55344 |
| Attn: General Counsel |

---

If to Executive: At his home address as then shown in the Company's personnel records, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) This Agreement is personal to Executive and shall not be assigned by Executive. Any purported assignment by Executive shall be null and void from the initial date of the purported assignment. The Company may assign this Agreement to any successor or assign (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company. This Agreement shall inure to the benefit of the Company and its successors and assigns.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) This Agreement contains the entire agreement of the parties with respect to the matters covered herein and supersedes all prior and contemporaneous agreements and understandings, oral or written, between the parties hereto concerning the subject matter hereof; *provided*, *however*, that the provisions of this Agreement are in addition to and complement (and do not replace or supersede) any other written agreement(s) or parts thereof between Executive and the Company that create restrictions on Executive with respect to confidentiality, non-disclosure, non-competition, non-solicitation or non-disparagement. Without limiting the scope of the preceding sentence, except as otherwise expressly provided in this <u>Section 19(c)</u>, all understandings and agreements preceding the Agreement Effective Date and relating to the subject matter hereof (including the Prior Agreement) are hereby null and void and of no further force or effect, and this Agreement shall supersede all other agreements, written or oral, that purport to govern the terms of Executive's employment (including Executive's compensation) with the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) No change or modification of this Agreement shall be valid unless the same shall be in writing and signed by all of the parties hereto. No waiver of any provisions of this Agreement shall be valid unless in writing and signed by the party charged with waiver. No waiver of any of the provisions of this Agreement shall be deemed, or shall constitute, a waiver of any other provision, whether or not similar, nor shall any waiver constitute a continuing waiver, unless so provided in the waiver.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) If any provisions of this Agreement (or portions thereof) shall, for any reason, be held invalid or unenforceable, such provisions (or portions thereof) shall be ineffective only to the extent of such invalidity or unenforceability, and the remaining provisions of this Agreement (or portions thereof) shall nevertheless be valid, enforceable and of full force and effect. If any court of competent jurisdiction finds that any restriction contained in this Agreement is invalid or unenforceable, then the parties hereto agree that such invalid or unenforceable restriction shall be deemed modified so that it shall be valid and enforceable to the greatest extent permissible under law, and if such restriction cannot be modified so as to make it enforceable or valid, such finding shall not affect the enforceability or validity of any of the other restrictions contained herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) The section or paragraph headings or titles herein are for convenience of reference only and shall not be deemed a part of this Agreement. The parties have jointly participated in the drafting of this Agreement, and the rule of construction that a contract shall be construed against the drafter shall not be applied. The terms "<u>including</u>," "<u>includes</u>," "<u>include</u>" and words of like import shall be construed broadly as if followed by the words "without limitation." The terms "<u>herein</u>," "<u>hereunder</u>," "<u>hereof</u>" and words of like import refer to this entire Agreement instead of just the provision in which they are found.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Notwithstanding anything to the contrary in this Agreement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The parties agree that this Agreement shall be interpreted to comply with or be exempt from Section 409A of the Code and the regulations and authoritative guidance promulgated thereunder to the extent applicable (collectively "<u>Section 409A</u>"), and all provisions of this Agreement shall be construed in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A. In no event whatsoever will the Company, any of its affiliates, or any of their respective directors, officers, agents, attorneys, employees, executives, shareholders, investors, members, managers, trustees, fiduciaries, representatives, principals, accountants, insurers, successors or assigns be liable for any additional tax, interest or penalties that may be imposed on Executive under Section 409A or any damages for failing to comply with Section 409A.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits considered "nonqualified deferred compensation" under Section 409A upon or following a termination of employment unless such termination is also a "separation from service" within the meaning of Section 409A, and for purposes of any such provision of this Agreement, references to a "resignation," "termination," "terminate," "termination of employment" or like terms shall mean separation from service. If any payment, compensation or other benefit provided to Executive in connection with the termination of his employment is determined, in whole or in part, to constitute "nonqualified deferred compensation" within the meaning of Section 409A and Executive is a specified employee as defined in Section 409A(2)(B)(i) of the Code, no part of such payments shall be paid before the day that is six (6) months plus one (1) day after the date of termination or, if earlier, ten business days following Executive's death (the "<u>New Payment Date</u>"). The aggregate of any payments that otherwise would have been paid to Executive during the period between the date of termination and the New Payment Date shall be paid to Executive in a lump sum on such New Payment Date. Thereafter, any payments that remain outstanding as of the day immediately following the New Payment Date shall be paid without delay over the time period originally scheduled, in accordance with the terms of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) All reimbursements for costs and expenses under this Agreement shall be paid in no event later than the end of the calendar year following the calendar year in which Executive incurs such expense. With regard to any provision herein that provides for reimbursement of costs and expenses or in-kind benefits, except as permitted by Section 409A, (i) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (ii) the amount of expenses eligible for reimbursements or in-kind, benefits provided during any taxable year shall not affect the expenses eligible for reimbursement or in-kind benefits to be provided in any other taxable year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) If under this Agreement, an amount is paid in two or more installments, for purposes of Section 409A, each installment shall be treated as a separate payment. Whenever a payment under this Agreement specifies a payment period with reference to a number of days (e.g., "payment shall be made within thirty (30) days following the date of termination"), the actual date of payment within the specified period shall be within the sole discretion of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) This Agreement, for all purposes, shall be construed in accordance with the laws of the State of Minnesota without regard to conflicts of law principles. Any action or proceeding by either of the parties to enforce or avoid this Agreement, or otherwise arising from or under the terms of this Agreement, shall be brought only in a state or federal court located in the State of Minnesota. The parties hereby irrevocably consent and submit to the jurisdiction of such courts, acknowledge the propriety of the venue there, and waive the defense of inconvenient forum to the maintenance of any such action or proceeding in such venue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) Other than the Company's right to seek injunctive relief or specific performance as provided in this Agreement, any dispute, controversy, or claim between Executive, on the one hand, and the Company, on the other hand, arising out of, under, pursuant to, or in any way relating to this Agreement and Executive's employment shall be submitted to and resolved by confidential and binding arbitration ("<u>Arbitration</u>"), administered by the American Arbitration Association ("<u>AAA</u>") and conducted pursuant to the rules then in effect of the AAA governing commercial disputes. The Arbitration hearing shall take place in Minneapolis, Minnesota. Such Arbitration shall be before three neutral arbitrators (the "<u>Panel</u>") licensed to practice law and familiar with commercial disputes. Any award rendered in any Arbitration shall be final and conclusive upon the parties to the Arbitration and not subject to judicial review, and the judgment thereon may be entered in the highest court of the forum (state or federal) having jurisdiction over the issues addressed in the Arbitration, but entry of such judgment will not be required to make such award effective. The Panel may enter a default decision against any party who fails to participate in the Arbitration. The administration fees and expenses of the Arbitration shall be borne equally by the parties to the Arbitration; <u>provided</u> that each party shall pay for and bear the cost of his/her/its own experts, evidence, and attorney's fees, except that, in the discretion of the Panel, any award may include the costs of a party's counsel and/or its share of the expense of Arbitration if the Panel expressly determines that an award of such costs is appropriate to the party whose position substantially prevails in such Arbitration. Notwithstanding any other provision of this Agreement, no party shall be entitled to an award of special, punitive, or consequential damages. To submit a matter to Arbitration, the party seeking redress shall notify in writing, in accordance with <u>Section 19(a)</u> of this Agreement, the party against whom such redress is sought, describe the nature of such claim, the provision of this Agreement that has been allegedly violated and the material facts surrounding such claim. The Panel shall render a single written, reasoned decision. The decision of the Panel shall be binding upon the parties to the Arbitration, and after the completion of such Arbitration, the parties to the Arbitration may only institute litigation regarding the Agreement for the sole purpose of enforcing the determination of the Arbitration hearing or, with respect to the Company, to seek injunctive or equitable relief pursuant to <u>Section 16</u> of this Agreement. The Panel shall have exclusive authority to resolve any dispute relating to the interpretation, applicability, enforceability or formation of this agreement to arbitrate, including any claim that all or part of this Agreement is void or voidable and any claim that an issue is not subject to arbitration. All proceedings conducted pursuant to this agreement to arbitrate, including any order, decision or award of the arbitrator, shall be kept confidential by all parties except to the extent such disclosure is required by law, or in a proceeding to enforce any rights under this Agreement.

EXECUTIVE ACKNOWLEDGES THAT, BY SIGNING THIS AGREEMENT, HE IS WAIVING ANY RIGHT THAT HE MAY HAVE TO A JURY TRIAL OR A COURT TRIAL RELATED TO THIS AGREEMENT.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) Executive hereby represents and warrants to the Company that (i) the execution, delivery and performance of this Agreement by Executive do not and shall not conflict with, breach, violate or cause a default under any contract, agreement, instrument, order, judgment or decree to which Executive is a party or by which he/she is bound and (ii) upon the execution and delivery of this Agreement by the Company, this Agreement shall be the valid and binding obligation of Executive on and after the Agreement Effective Date, enforceable in accordance with its terms. Executive hereby acknowledges and represents that he has had the opportunity to consult with independent legal counsel or other advisor of his choice and has done so regarding his rights and obligations under this Agreement, that he is entering into this Agreement knowingly, voluntarily, and of his own free will, that he is relying on his own judgment in doing so, and that he fully understands the terms and conditions contained herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) The Company shall have the right to withhold from any amount payable hereunder any Federal, state and local taxes in order for the Company to satisfy any withholding tax obligation it may have under any applicable law or regulation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) The covenants and obligations of the Company under <u>Sections 10, 15, 16 and 17</u> hereof, and the covenants and obligations of Executive under <u>Sections 10, 12, 13, 14, 15, 16 and 17</u> hereof, shall continue and survive any expiration of the Term, termination of Executive's employment or any termination of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) <u>Representation by Counsel</u>. Executive acknowledges and agrees that Executive was represented by counsel in connection with the negotiation of this Agreement. Executive acknowledges and agrees that the Company's principal place of business and headquarters are located in Minneapolis, Minnesota, and even though Executive may not be physically located in the State of Minnesota at all times for the performance of all of Executive's duties and responsibilities under this Agreement, Executive will be required to travel routinely to Minnesota on business on behalf of the Company and Executive's employment is effectively providing services to the Company within the State of Minnesota. Executive acknowledges and agrees that any equity awards made pursuant to the Incentive Plan, or any successor plan, will be subject to governing law and dispute provisions set forth therein, to which Executive shall be bound in all respects. Executive further acknowledges and agrees that pursuant to Section 925 of the California Labor Code, (i) Executive has waived the application of California law to this Agreement and any proceeding, (ii) Executive has waived any right to have any proceeding adjudicated in California, and (iii) Executive acknowledges and agrees that any proceeding shall not be deemed to be a controversy arising in California.

[*signature page follows*]

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

---

| | |
|:---|:---|
| AGILITI, INC. | AGILITI, INC. |
| By: | /s/ ROBERT L. CREVISTON |
|  | By: Robert L. Creviston |
|  | Title: Chief Human Resources Officer |

---

---

| |
|:---|
| /s/ THOMAS W. BOEHNING |
| Thomas W. Boehning |

---

[*Signature Page to Amended & Restated Employment Agreement*]

**<u>ATTACHMENT A</u>**

This Release ("Release") between Agiliti, Inc. (hereinafter "Company") and you relate to your termination from employment with the Company and its subsidiaries, which will be effective on ___________ ("Termination Date").

**<u>Release of Claims</u>**

In consideration of and subject to the performance by the Company and its subsidiaries and affiliates of its obligations under Section 10 of the Amended and Restated Employment Agreement, entered into on January 10, 2023, between you the Company, you agree on your own behalf and on behalf of anyone claiming rights through you, to fully and finally release, waive and forever discharge the Company, its subsidiaries and other affiliates, successors, past and present officers, directors, committees, employees, insurers, agents, attorneys, associates and employee benefit plans (collectively "Released Parties") from all claims, demands or causes of action arising out of facts or occurrences before and as of the date of this Release, whether known or unknown to you; however, you are not prohibited from pursuing claims for any employee benefit vested and accrued in your favor as of your Termination Date.

You agree that this Release is intended to be broadly construed so as to resolve any pending and potential disputes between you and the Released Parties that you have up to the date of your acceptance of this Release, whether such disputes are known or unknown to you, including, but not limited to, claims based on express or implied contract; any administrative agency action or proceeding to the extent allowed by law; any action arising in tort, including, but not limited to interference with contractual or business relationships, breach of fiduciary duty, promissory or equitable estoppel, invasion of privacy, libel, slander, defamation, intentional infliction of emotional distress, or negligence; any or all claims for wrongful discharge, breach of a covenant of good faith and fair dealing; and any and all claims including but not limited to those based on the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act, Title VII of the Civil Rights Act, the Civil Rights Act of 1991, the Employment Retirement Income Security Act, the Family and Medical Leave Act, the Americans With Disabilities Act, the State of Minnesota Human Rights Act**,** other applicable state human rights laws and any other applicable federal, state, local or foreign law, regulation, ordinance or order. The above release of claims does not include: (i) any claims that the law does not allow to be waived, (ii) any rights you may have on or after the date hereof in connection with any equity you may have been granted to the extent such equity is retained following the termination of your employment, (iii) any rights you may have to reimbursement, indemnification, or contribution in connection with any claims by third parties that arise out of or relate to your employment with the Company or any positions held by you at the request of the Company, or (iv) any claims that may arise after the date you sign this Release. This release of claims also does not prohibit you from filing any charge or complaint with, or participating in any investigation or proceeding conducted by, the Equal Employment Opportunity Commission ("EEOC"). Notwithstanding the foregoing, you release and waive any right you may have to obtain monetary relief or compensation awarded by the EEOC. You further agree to not voluntarily assist or participate in any lawsuits brought by other individuals against the Released Party, unless such assistance is requested by the Company or the Released Party or such participation is required or protected by law.

**<u>Acceptance of this Release</u>**

You acknowledge that, before signing this Release, you were given a period of at least [21][45] days from the date of receipt of this Release to consider it. To accept the terms of this Release, you must sign and date it within the [21][45]-day consideration period or by the end of the workday on your Termination Date, whichever is later. **You may not sign this Release before your Termination Date.** After you have signed and dated this Release, you must send or return it to the Company by hand or by mail within the [21][45]-day period that you have to consider it. Any changes to this Release whether material or not will not restart the running of the [21][45]-day period.

To accept this Release, sign and return it to the Chief Human Resources Officer, Agiliti, Inc., 11095 Viking Drive, Suite 300, Eden Prairie, MN 55344.

If you choose to return this Release by mail, it must be properly addressed and postmarked within the [21][45]-day consideration period and sent by certified mail, return receipt requested, first-class postage prepaid.

If you sign this Release before the end of the [21][45]-day consideration period, it will be your voluntary decision to do so because you have decided that you do not need any additional time to decide whether to sign it. You waive any right you might have to additional time beyond the [21][45]-day consideration period within which to consider this Release.

You have been advised by the Company to consult with an attorney before signing this Release and this sentence constitutes such advice in writing.

**<u>Rescission of this Release</u>**

At any time for a period of 15 days after you have signed this Release (not counting the day you signed it), you may rescind it. This Release will not become effective or enforceable until the 15-day rescission period has expired without you rescinding it. To rescind your acceptance, you must send by mail or hand-deliver a written, signed statement of rescission of your acceptance to the Company within the 15-day rescission period. Any statement of recession of acceptance must be directed to the Chief Human Resources Officer, Agiliti, Inc., 11095 Viking Drive, Suite 300, Eden Prairie, MN 55344. If you choose to return it by mail, it must be properly addressed and postmarked within 15 days after you signed the Release and sent by certified mail, return receipt requested, first-class postage prepaid.

**<u>Governing Law and Construction</u>**

This Release may not be changed, except in a writing that details the change and is signed by both you and the Company.

This Release will be governed and enforced solely under the laws of the State of Minnesota, without giving effect to the conflicts of law principles thereof. If any portion of this Release is deemed to be invalid or unenforceable, that portion will be deemed omitted and the remainder of this Release will remaining effect.

**<u>Remedies for Breach</u>**

If you breach or challenge the enforceability of this Release and do not prevail, you agree to reimburse the Company for any monetary consideration received by you pursuant to this Release and you agree to pay the reasonable attorneys' fees and costs that the Company incurs in enforcing this Release; provided, however, that this provision has no applicability to claims that cannot be waived under the Age Discrimination in Employment Act, including the right to challenge whether this Release constitutes a knowing and voluntary waiver of claims within the meaning of the Act.

**<u>Acknowledgement</u>**

**By my signature below, I acknowledge and certify that:**

a. I have read and understand all of the terms of this Release and do not
 rely on any representation or statement, written or oral, not set forth in this Release;
 specifically, I understand that this Release includes a waiver and release of legal
 rights I may have;

b. I have had a reasonable period of time to consider this Release;

c. I am signing this Release knowingly and voluntarily and without pressure,
 and after having given the matter full and careful consideration;

d. I have been advised to consult with an attorney of my choosing before
 signing this Release and I have had the opportunity to do so;

e. I have the right to consider the terms of this Release for at least [21][45]
 days and if I take fewer than [21][45] days to review this Release, I hereby waive any
 and all rights to the balance of the [21][45]-day review period;

f. I have the right to revoke this Release within 15 days after signing it,
 by providing written notice of revocation directed to Chief Human Resources Officer, Agiliti, Inc.,
 11095 Viking Drive, Suite 300, Eden Prairie, MN 55344. If I revoke this Release during
 this 15-day period, it becomes null and void in its entirety; and

g. This Release is not effective if it is signed before my Termination Date.

If you accept this Release, please sign both copies, and then return both signed original copies to Chief Human Resources Officer, Agiliti, Inc., 11095 Viking Drive, Suite 300, Eden Prairie, MN 55344 for countersignature. We will send you a fully executed original for your records.

---

| | |
|:---|:---|
| AGILITI, INC. | THOMAS W. BOEHNING |
| Date: | Date: |

---

## Exhibit 99.1

**Exhibit 99.1**

**AGILITI ANNOUNCES LEADERSHIP SUCCESSION**

*Tom Leonard to retire following the close of first quarter 2023<br> Tom Boehning, President, to succeed as Agiliti CEO*

Minneapolis, Minn.--(BUSINESS WIRE)— January 9, 2023 – Agiliti, Inc. (NYSE: AGTI) ("Agiliti"), a nationwide provider of medical technology management and service solutions to the United States healthcare industry, today announced that Tom Leonard will retire as Agiliti CEO on March 10, 2023, and continue on as a member of the company's Board of Directors. Tom Boehning, currently President, will succeed Leonard as Chief Executive Officer and join the Agiliti Board of Directors beginning March 10, 2023. Mr. Leonard will remain an employee of the Company to assist with the transition of his executive responsibilities to Mr. Boehning until March 31, 2023.

"Tom Boehning has been integral to our growth and evolution during his tenure as President," said Tom Leonard, CEO of Agiliti. "In his first three years at the company, he led the expansion of our solution offering and elevated Agiliti's commercial capabilities, bringing more of our critical services to our more than 9,000 customers. His unwavering commitment to our essential role in healthcare is evident in our strong growth momentum, and our proven track record of creating value for shareholders."

"I am honored to succeed Tom as CEO of Agiliti," said Tom Boehning, President of Agiliti. "Since joining the company, I've had the pleasure of working alongside our colleagues and customers to deliver on our critical mission—always with a focus on improving the value we bring to our customers and our shareholders. Underlying Agiliti's results and reputation is the strength and resilience of its business model, its nationwide scale and dedication to quality and service. It is a privilege to lead this team, and I look forward to furthering our partnerships and delivering on our proven growth strategy in the years to come."

Boehning joined Agiliti in January 2020 as the company's President overseeing its Commercial organization of more than 5,000 sales, clinical and operations team members. He previously spent 13 years at Optum where he was CEO of their joint venture, Optum360—the nation's largest independent revenue cycle services organization. In his more than 25 years in healthcare, he has held executive leadership roles across nearly every sector of healthcare delivery, technology and reimbursement. Boehning holds a bachelor's degree in Economics and an MBA from Pennsylvania State University.

"This transition is a result of a thoughtful and deliberate succession planning process completed by our Board of Directors," said Leonard. "We have every confidence that Tom Boehning is the right next leader to sustain Agiliti's proud heritage and propel the company's continued progress through its next era of growth."

Scott Sperling, Agiliti board member and Co-Chief Executive Officer of Thomas H. Lee Partners, the company's largest shareholder, added, "Under Tom Leonard's leadership, Agiliti transformed from an equipment rental company to an essential provider of comprehensive medical technology solutions to the U.S. healthcare industry. We greatly appreciate his accomplishments during his eight years as CEO, and we look forward to the company's continued growth under Tom Boehning's vision and leadership."

**About Agiliti**

Agiliti is an essential service provider to the U.S. healthcare industry with solutions that help support a more efficient, safe and sustainable healthcare delivery system. Agiliti serves more than 9,000 national, regional and local acute care and alternate site providers across the U.S. For more than eight decades, Agiliti has delivered medical equipment management and service solutions that help healthcare providers reduce costs, increase operating efficiencies and support optimal patient outcomes.

CONTACT:

Kate Kaiser

Corporate Communication and Investor Relations

kate.kaiser@agilitihealth.com

**Forward-Looking Statements**

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements in this press release are forward-looking in time, including statements regarding growth and strategy, and involve risks and uncertainties. The following factors, among others, could adversely affect our business, operations and financial condition causing our actual results to differ materially from those expressed in any forward-looking statements: negative reaction of our investors, our suppliers, our customers or our employees to our leadership succession; market volatility of our common stock as a result of our leadership succession; the risk that the leadership succession may not provide the results that the company expects; our history of net losses and substantial interest expense; our need for substantial cash to operate and expand our business as planned; our substantial outstanding debt and debt service obligations; restrictions imposed by the terms of our debt; a decrease in the number of patients our customers are serving; our ability to effect change in the manner in which health care providers traditionally procure medical equipment; the absence of long-term commitments with customers; our potential inability to maintain the agreement with HHS and ASPR (the "Agreement") or comply with its terms and risks relating to extension, renewal or termination of the Agreement or any of our existing contacts with HHS and ASPR; our ability to renew contracts with group purchasing organizations and integrated delivery networks; changes in reimbursement rates and policies by third-party payors; the impact of health care reform initiatives; the impact of significant regulation of the health care industry and the need to comply with those regulations; the effect of prolonged negative changes in domestic and global economic conditions; difficulties or delays in our continued expansion into certain of our businesses/geographic markets and developments of new businesses/geographic markets; additional credit risks in increasing business with home care providers and nursing homes, impacts of equipment product recalls or obsolescence; increases in vendor costs that cannot be passed through to our customers; and other Risk Factors as detailed in our most recent annual report on Form 10-K.